DermBiont is advancing SM-030, a topical PKC-beta inhibitor for the treatment of melasma and other hyperpigmentation disorders of the skin.
DermBiont is advancing SM-030, a topical PKC-beta inhibitor for the treatment of melasma and other hyperpigmentation disorders of the skin.